THE INVESTORS/SECTORS/BIOTECHNOLOGY

// SECTOR INVESTOR DOSSIER

Investors in Biotechnology

51 investors with active positions in Biotechnology unicorns — combined exposure across this sector $321B in paper valuation.

Note: combined paper valuation reflects overlapping investor positions — individual investors hold stakes in the same companies.